SecBot SecBot
SECBOTREPLAY Home › Report › NVO

NVO · Novo Nordisk filed a routine 6-K updating its ongoing share repurchase…

NOVO NORDISK A S · 6-K filed Nov 3, 2026 at 10:54 ET

At the news

NEUTRALIMPACT 2/10

6-K filed Nov 3, 2026 at 10:54 ET

Novo Nordisk filed a routine 6-K updating its ongoing share repurchase program, reporting the repurchase of 1.44 million B shares for approximately DKK 377 million during the week ended November 2, 2026. The filing is a standard periodic update with no material new information about the company's financial performance or outlook.

  • Novo Nordisk repurchased 1,440,000 B shares from October 26 to November 2, 2026, at an average price of DKK 261.85 per share, for a total transaction value of approximately DKK 377 million.
  • Since the program's initiation on May 6, 2026, the company has repurchased 26,955,000 B shares for a total of DKK 7,764,364,812.
  • The overall share repurchase program authorizes up to DKK 15 billion over a 12-month period beginning February 4, 2026; as of November 2, 2026, Novo Nordisk has repurchased 41,714,179 B shares at an average price of DKK 277.23 per share, totaling DKK 11,564,364,801.
  • Novo Nordisk holds 55,754,876 B shares as treasury shares, representing 1.2% of the total share capital of 4,465,000,000 shares.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access